Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
Aladdin Mohammad, Professor of Rheumatology at Lund University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers, adding:
”I am pleased to share our latest publication: Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab
Rituximab has become a cornerstone in the management of ANCA-associated vasculitis (AAV), but concerns remain regarding treatment-related hypogammaglobulinaemia and the associated risk of infections.
In this population-based Swedish cohort of patients with AAV treated with rituximab, we found that:
- Hypogammaglobulinaemia developed in 45% of patients.
- Most cases were mild to moderate.
- Lower baseline IgG levels independently predicted the development of hypogammaglobulinaemia.
- Hypogammaglobulinaemia was not associated with an increased risk of severe infections in this cohort.
These findings emphasize the importance of measuring IgG levels before initiating rituximab and monitoring them throughout treatment, particularly in patients with lower baseline IgG concentrations.
Many thanks to my co-authors Jens Rathmann, Hiba Kadhem, Mårten Segelmark, and David Jayne for their excellent collaboration.”
Title: Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab
Authors: Jens Rathmann, Hiba Kadhem, Mårten Segelmark, David Jayne, Aladdin J. Mohammad

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics